Harrow Health is trading at $41.94, up +5.38%, outperforming as the Nasdaq Composite rises 0.54% and the broader market remains positive on August 25, 2026.
- No new company-specific announcement or analyst action directly tied to the move was identified.
- The latest official item, August 20 IHEEZO data, reported patient-discomfort findings but did not explicitly link them to today’s trading.